ORIX CORPORATION : ORIX Ventures Announces $10 Million Growth Capital Commitment to Talyst
11/07/2012| 10:10am US/Eastern
Funding Supports Growth of Market Leader in Pharmacy Automation and
ORIX Ventures announces the closing of a $10 million growth capital
commitment to Talyst. The funding is structured to provide immediate
growth capital to the company. Initial proceeds will be used to support
Talyst's expansion into the long-term care and correctional markets, as
well as its plans to achieve greater penetration in acute-care market.
Located in Seattle, Washington, Talyst is a leader in pharmacy
automation providing enterprise-wide medication management across entire
health systems. Its solutions offer greater inventory control, enhanced
workflow efficiency and improved patient safety. Talyst was founded in
2002 to provide easy-to-use, automated medication management systems to
acute-care hospital pharmacies.
The funding of Talyst underscores ORIX Ventures' intent to forge
partnerships with fast-growing, later stage companies, as well as its
particular interest in health care companies.
"We believe this funding from ORIX Ventures validates the market
leadership and growth potential of Talyst," said CEO Carla Corkern.
"Having a strong partner, such as ORIX Ventures, which can support the
financial needs of Talyst throughout our expansion gives us a
competitive edge by enabling us to respond quickly to marketplace
David Orlandella, a Principal at ORIX Ventures, commented, "We are
pleased to partner with Talyst's management team which has demonstrated
an impressive ability to strategically scale the company and build a
leading technology company in the pharmacy automation space."
About ORIX Ventures
ORIX Ventures provides customized financial solutions up to $50 million
in capital per transaction to mid- and late-stage companies which have
established customers and run-rate revenues of $10 million or greater.
Since its inception in 2001, ORIX Ventures has invested in more than 100
growth companies throughout the U.S. and Canada. www.orixventures.com.
ORIX USA is a Dallas, Texas-based financial services and investment firm
with more than 1,400 employees and primary offices in Dallas, New York,
Los Angeles, Columbus and Minneapolis. ORIX USA holds approximately $6
billion of assets and manages through various subsidiaries an additional
$25 billion. www.orix.com.
ORIX USA is a wholly owned subsidiary of ORIX Corporation, a
Tokyo-based, publicly owned international financial services company
with operations in 27 countries worldwide. ORIX Corporation is listed on
the Tokyo (8591) and New York Stock Exchanges (IX).
Follow us on Twitter: @orixventures
Talyst is a leader in pharmacy automation and engineers the safer
pharmacy. The company's solutions provide enterprise-wide medication
management across entire health systems to offer greater inventory
control, enhanced workflow efficiency, and improved patient safety. As
of 2012, Talyst has installed automated systems in more than 600
integrated healthcare systems, acute-care hospitals, long-term care
facilities, and correctional institutions. Talyst offers a powerful
software platform with a suite of hardware components to meet specific
needs of health care providers. Visit Talyst at www.talyst.com.
C. Pharr & Company for ORIX Ventures
Shelby Sabin Menczer,
© Business Wire 2012